Seroatlas · Human Serome Atlas

WFDC2

WAP four-disulfide core domain protein 2

Also known as: dJ461P17.6, EDDM4, HE4, WAP5, WFDC2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q14508
Gene
WFDC2
Ensembl
ENSG00000101443
Chromosome
20
Canonical length
124 aa
Protein class
Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted in other tissues
Quaternary structure
Homotrimer

OverviewNCBI Gene

This gene encodes a protein that is a member of the WFDC domain family. The WFDC domain, or WAP Signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. This gene is expressed in pulmonary epithelial cells, and was also found to be expressed in some ovarian cancers. The encoded protein is a small secretory protein, which may be involved in sperm maturation. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

124 residues, UniProt reviewed canonical sequence.

>Q14508|WFDC2
     1  MPACRLGPLA AALLLSLLLF GFTLVSGTGA EKTGVCPELQ ADQNCTQECV SDSECADNLK
    61  CCSAGCATFC SLPNDKEGSC PQVNINFPQL GLCRDQCQVD SQCPGQMKCC RNGCGKVSCV
   121  TPNF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against WFDC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.43
Highest tissue expression
4,906 nTPM

Expression across tissuesHPA

Tissue

  • cervix: 4,906 nTPM
  • salivary gland: 1,869 nTPM
  • kidney: 938 nTPM
  • epididymis: 889 nTPM
  • seminal vesicle: 779 nTPM
  • fallopian tube: 636 nTPM

Single-cell type

  • conjunctival goblet cells: 39,115 nCPM
  • salivary duct cells: 38,883 nCPM
  • endometrial secretory cells: 17,350 nCPM
  • respiratory secretory cells: 10,775 nCPM
  • submucosal glandular cells: 10,205 nCPM
  • respiratory deuterosomal cells: 8,385 nCPM

Immune cell

  • plasmacytoid DC: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • choroid plexus: 37 nTPM
  • basal ganglia: 19 nTPM
  • midbrain: 8.6 nTPM
  • cerebral cortex: 7.8 nTPM
  • medulla oblongata: 5.8 nTPM
  • hypothalamus: 5.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about WFDC2.

Disease | AllUniProt

Conditions WFDC2 is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 34 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

ReferencesPubMed · IEDB

Publications for WFDC2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.57
gnomAD pLI
0.79
gnomAD missense Z
0.06
DepMap mean gene effect
-0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of WFDC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads WFDC2 as an antibody target. Whether an autoantibody or antibody against WFDC2 could matter depends on whether native WFDC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

WFDC2 is annotated as secreted, so native WFDC2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label WFDC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/WFDC2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...